Rheumatoid bursitis at an unspecified anatomical site — bursal inflammation occurring in the context of rheumatoid disease where the treating provider has not documented or identified the specific joint location.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M06.20.
Source · Editorial brief grounded in 5 cited references ↓
- Document the specific joint where bursal inflammation is present (e.g., olecranon, subacromial, prepatellar) — this upgrades M06.20 to a site-specific M06.2xx code and reduces audit risk.
- Record the laterality (right vs. left) alongside the joint name so the 6th-character specificity of child codes (e.g., M06.261 right knee, M06.262 left knee) can be applied.
- Confirm and document the rheumatoid etiology explicitly in the note — distinguish from non-inflammatory bursitis (M71.x) or crystal-induced bursopathy so the correct code family is used.
- Include relevant serologic findings (RF, anti-CCP) or rheumatology consultation notes that support a rheumatoid diagnosis, especially when billing alongside orthopedic procedures.
- If multiple bursae are involved, document each site; M06.29 (multiple sites) may be more accurate than M06.20 (unspecified site) and better reflects disease burden.
Related CPT procedures
Procedure codes commonly billed with M06.20. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M06.20 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Coding M06.20 when the provider's note actually names the joint — always check for a documented site before defaulting to unspecified; payers can deny or downcode claims where specificity was available.
- Routing to M71.9 (Bursopathy, unspecified / Bursitis NOS) instead of M06.20 when the etiology is explicitly rheumatoid — the Alphabetic Index cross-reference sends 'Bursitis, rheumatoid' to M06.20, not M71.9.
- Omitting the concurrent rheumatoid arthritis diagnosis code when it is also being managed during the same encounter — M06.20 describes the bursitis manifestation; the RA itself may warrant a separate code from the M05–M06 range.
- Using M06.20 for seronegative bursitis without documented rheumatoid disease — confirm the rheumatoid etiology is established before selecting any M06.2x code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M06.20 is the fallback code within the M06.2 (Rheumatoid bursitis) family when the affected bursa's anatomical site is not documented. The M06.2x series spans shoulder (M06.21x), elbow (M06.22x), wrist (M06.23x), hand (M06.24x), hip (M06.25x), knee (M06.26x), ankle and foot (M06.27x), vertebrae (M06.28), and multiple sites (M06.29). If the provider documents any of those locations, skip M06.20 entirely and use the site-specific code — payers and CMS both flag unspecified-site codes when a more specific option was available and documentable.
Rheumatoid bursitis is classified under Other Rheumatoid Arthritis (M06), not under the general bursopathy category (M71.9). The ICD-10-CM Alphabetic Index cross-references 'Bursitis, rheumatoid' directly to M06.20, which means coders encountering a generic 'rheumatoid bursitis' note without site detail will land here by default. That cross-reference also confirms M06.20 is the correct code — not M71.9 — when the etiology is explicitly rheumatoid.
In orthopedic practice, rheumatoid bursitis most commonly presents at the shoulder (subacromial), elbow (olecranon), or knee (prepatellar/infrapatellar) in patients with established RA. If the treating orthopedist's note identifies the joint, query for site-specific coding before submitting M06.20. Use M06.20 only when site documentation is genuinely absent and a query is not feasible.
Sibling codes
Other billable codes under M06.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When should I use M06.20 instead of a site-specific M06.2xx code?
02Is M06.20 the correct code when the note just says 'rheumatoid bursitis' with no other detail?
03Can I use M71.9 (Bursitis NOS) for a patient with RA who has bursitis?
04Should I also code the underlying rheumatoid arthritis when billing M06.20?
05Does M06.20 require a 7th-character extension?
06What CPT procedures are commonly billed with M06.20?
07Can M06.20 be used for multiple bursae affected by rheumatoid disease?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M06-/M06.20
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M06.20
- 04rheumatologyadvisor.comhttps://www.rheumatologyadvisor.com/diagnostic-update/rheumatology-icd-10-codes/
- 05cms.govhttps://www.cms.gov/medicare/coding/icd10/downloads/icd10clinicalconceptsorthopedics1.pdf
Mira AI Scribe
Mira's AI scribe captures the joint location of bursal swelling or tenderness, the treating provider's documented etiology (rheumatoid vs. mechanical), serologic context (RF/anti-CCP status), and laterality from the encounter note. Locking these details at documentation prevents a drop to M06.20 (unspecified site) when a site-specific M06.2xx code is clinically supported — avoiding specificity downgrades and payer audit flags.
See how Mira captures M06.20 documentation